.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Novartis
Cantor Fitzgerald
Daiichi Sankyo
US Department of Justice
Merck
Chubb
Healthtrust
Chinese Patent Office
Dow

Generated: July 24, 2017

DrugPatentWatch Database Preview

Drug Master Files for: theophylline

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
539III4/25/1963GANES CHEMICALS INC PENNSVILLE DIV7 BETA-HYDROXYPROPYL THEOPHYLLINE
1911III4/4/1972GANES CHEMICALS INC PENNSVILLE DIV8 - BROMOTHEOPHYLLINE
2730III8/27/1976CONCORD LABORATORIES INCTHEOPHYLLINE CAPS., 250MG
2864III2/24/1977BOEHRINGER MANNHEIM GMBHDIHYDROXYPROPYLTHEOPHYLLINE (DYPHYLLINE)
3040III10/24/1977CONCORD LABORATORIES INCTHEOPHYLLINE CAP
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Teva
Harvard Business School
Daiichi Sankyo
Johnson and Johnson
Fish and Richardson
Argus Health
Cantor Fitzgerald
Cipla
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot